Kitrinor Metals Inc.

• Scythian Biosciences Corp. (formerly Kitrinor Metals Inc.) Closes Reverse Takeover Transaction

  Scythian Biosciences, formerly Kitrinor Metals is pleased to announce the closing of the previously announced three-cornered amalgamation whereby Scythian Biosciences merged with a wholly-owned subsidiary of Kitrinor. The Transaction constituted a change of business and a reverse takeover transaction of Kitrinor pursuant to the TSX Venture Exchange Policy 5.2 – Changes of Business and Reverse Takeovers.

  weiterlesen

  03.08.2017

  von GlobeNewswire
• Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Signing of Business Combination Agreement

  Further to its press releases dated March 31, March 14, and February 21, Kitrinor Metals and Scythian Biosciences are pleased to announce the execution on June 6, 2017 of a business combination agreement among Scythian, the Company and 10188760 Canada Inc., a wholly-owned subsidiary of the Company incorporated under the federal laws of Canada which, subject to certain conditions and applicable shareholder, director [...]

  weiterlesen

  14.06.2017

  von GlobeNewswire
• Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Closing of Second Tranche of Subscription Receipt Financing and Common Share Offering

  Further to the press releases dated February 21, 2017 and March 14, 2017, Kitrinor Metals and Scythian Biosciences are pleased to announce that Scythian completed the second tranche of its previously announced brokered private placement offering of subscription receipts led by Clarus Securities Inc., together with Haywood Securities Inc. and Canaccord Genuity Corp., for additional gross proceeds of C$200,000 [...]

  weiterlesen

  31.03.2017

  von Marketwire
• Kitrinor Metals and Scythian Biosciences Announce Closing of Subscription Receipt Financing of $13,085,000 With Strategic Lead Investment From Aphria Inc.

  Further to the press release dated February 21, 2017, Kitrinor Metals and Scythian Biosciences, a company incorporated under the federal laws of Canada, are pleased to announce that Scythian completed an initial tranche of a brokered private placement offering of subscription receipts led by Clarus Securities, together with Haywood Securities and Canaccord Genuity, for gross proceeds of C$13,085,000. The Offering was [...]

  weiterlesen

  14.03.2017

  von Marketwire
• Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Reverse Takeover Transaction

  Kitrinor Metals is pleased to announce that it has entered into a non-binding letter of intent dated February 17, with Scythian Biosciences Inc., a private Canadian corporation, in connection with a proposed reverse take-over of the Company, subject to approval of the TSXV, to list the shares of the resulting entity on the TSXV. The Resulting Issuer will operate as a life sciences issuer continuing the business

  weiterlesen

  21.02.2017

  von Marketwire

weitere engl. Meldungen